Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA 3rd, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P. Maron BJ, et al. Among authors: favale s. JAMA. 2007 Jul 25;298(4):405-12. doi: 10.1001/jama.298.4.405. JAMA. 2007. PMID: 17652294
Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
Corrado D, Calkins H, Link MS, Leoni L, Favale S, Bevilacqua M, Basso C, Ward D, Boriani G, Ricci R, Piccini JP, Dalal D, Santini M, Buja G, Iliceto S, Estes NA 3rd, Wichter T, McKenna WJ, Thiene G, Marcus FI. Corrado D, et al. Among authors: favale s. Circulation. 2010 Sep 21;122(12):1144-52. doi: 10.1161/CIRCULATIONAHA.109.913871. Epub 2010 Sep 7. Circulation. 2010. PMID: 20823389
Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy.
Cecconi M, Parodi MI, Formisano F, Spirito P, Autore C, Musumeci MB, Favale S, Forleo C, Rapezzi C, Biagini E, Davì S, Canepa E, Pennese L, Castagnetta M, Degiorgio D, Coviello DA. Cecconi M, et al. Among authors: favale s. Int J Mol Med. 2016 Oct;38(4):1111-24. doi: 10.3892/ijmm.2016.2732. Epub 2016 Sep 7. Int J Mol Med. 2016. PMID: 27600940 Free PMC article.
Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant.
Brignole M, Occhetta E, Bongiorni MG, Proclemer A, Favale S, Iacopino S, Calò L, Vado A, Buja G, Mascioli G, Quartieri F, Tritto M, Parravicini U, Castro A, Tomasi C, Villani GQ, D'Acri MG, Klersy C, Gasparini M; SAFE-ICD Study Investigators. Brignole M, et al. Among authors: favale s. J Am Coll Cardiol. 2012 Sep 11;60(11):981-7. doi: 10.1016/j.jacc.2012.05.014. Epub 2012 Aug 1. J Am Coll Cardiol. 2012. PMID: 22858384 Free article. Clinical Trial.
Heart rate variability patterns before ventricular tachycardia onset in patients with an implantable cardioverter defibrillator. Participating Investigators of ICD-HRV Italian Study Group.
Lombardi F, Porta A, Marzegalli M, Favale S, Santini M, Vincenti A, De Rosa A; Implantable Cardioverter Defibrillator-Heart Rate Variability Italian Study Group. Lombardi F, et al. Among authors: favale s. Am J Cardiol. 2000 Nov 1;86(9):959-63. doi: 10.1016/s0002-9149(00)01130-9. Am J Cardiol. 2000. PMID: 11053707 Clinical Trial.
Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events.
Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Zolezzi F, Favale S, Molon G, Ricci R, Biffi M, Russo G, Vimercati M, Corbucci G, Boriani G. Botto GL, et al. Among authors: favale s. J Cardiovasc Electrophysiol. 2009 Mar;20(3):241-8. doi: 10.1111/j.1540-8167.2008.01320.x. Epub 2008 Oct 30. J Cardiovasc Electrophysiol. 2009. PMID: 19175849 Clinical Trial.
Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers.
Capucci A, Santini M, Padeletti L, Gulizia M, Botto G, Boriani G, Ricci R, Favale S, Zolezzi F, Di Belardino N, Molon G, Drago F, Villani GQ, Mazzini E, Vimercati M, Grammatico A; Italian AT500 Registry Investigators. Capucci A, et al. Among authors: favale s. J Am Coll Cardiol. 2005 Nov 15;46(10):1913-20. doi: 10.1016/j.jacc.2005.07.044. Epub 2005 Oct 24. J Am Coll Cardiol. 2005. PMID: 16286180 Free article.
Temporal variability of atrial fibrillation in pacemaker recipients for bradycardia: implications for crossover designed trials, study sample size, and identification of responder patients by means of arrhythmia burden.
Botto GL, Santini M, Padeletti L, Boriani G, Luzzi G, Zolezzi F, Orazi S, Proclemer A, Chiarandà G, Favale S, Solimene F, Luzi M, Vimercati M, DeSanto T, Grammatico A. Botto GL, et al. Among authors: favale s. J Cardiovasc Electrophysiol. 2007 Mar;18(3):250-7. doi: 10.1111/j.1540-8167.2006.00731.x. Epub 2007 Jan 30. J Cardiovasc Electrophysiol. 2007. PMID: 17284291
166 results